Question

Difficulty: MediumMonitoring and Treatment Evaluation

A 42-year-old woman presents to the emergency department with a 2-day history of high fever, chills, and severe sore throat. She was diagnosed with hyperthyroidism due to Graves' disease 4 weeks ago and was started on methimazole and propranolol. Her temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure is 110/70110/70 mm Hg, heart rate is 112112/min, and respiratory rate is 1818/min. Physical examination reveals marked pharyngeal erythema with tonsillar exudates but no neck asymmetry or airway compromise. Laboratory studies show:

TestResult
Hemoglobin12.4 g/dL12.4\text{ g/dL}
Platelets210,000/mm3210,000/\text{mm}^3
Leukocytes900/mm3900/\text{mm}^3
Neutrophils15%15\%
Lymphocytes80%80\%
Monocytes5%5\%

Which of the following is the most appropriate next step in the management of this patient?

  1. Discontinue methimazole, admit to the hospital, and initiate intravenous broad-spectrum antibioticsAnswer
  2. B
    Discontinue methimazole, prescribe oral amoxicillin-clavulanate, and arrange 24-hour outpatient follow-up
  3. C
    Discontinue methimazole, initiate propylthiouracil, and admit to the hospital for observation
  4. D
    Continue methimazole, administer intramuscular penicillin G benzathine, and discharge home
  5. E
    Discontinue methimazole, begin intravenous antibiotics, and perform an immediate bone marrow biopsy

Answer

Discontinue methimazole, admit to the hospital, and initiate intravenous broad-spectrum antibiotics
The correct answer identifies the need to stop the offending medication and aggressively treat the resulting immunocompromised state. This patient has developed methimazole-induced agranulocytosis, an idiosyncratic and life-threatening adverse effect of thionamides that most frequently occurs within the first 90 days of therapy. Her absolute neutrophil count (ANC) is 135/mm3135/\text{mm}^3 (900/mm3×15%900/\text{mm}^3 \times 15\%). An ANC less than 500/mm3500/\text{mm}^3 in the presence of fever defines febrile neutropenia, a medical emergency. The most appropriate next step in management is the immediate discontinuation of methimazole, hospital admission, and prompt initiation of intravenous broad-spectrum antibiotics (such as cefepime, meropenem, or piperacillin-tazobactam) to provide empiric coverage against typical pathogens, particularly *Pseudomonas aeruginosa*. Once recovered, definitive management of her Graves' disease will likely require radioactive iodine ablation or surgery.

Step-by-Step Solution

1
Calculate the Absolute Neutrophil Count (ANC).
ANC=Total Leukocytes×Percentage of Neutrophils=900×0.15=135/mm3\text{ANC} = \text{Total Leukocytes} \times \text{Percentage of Neutrophils} = 900 \times 0.15 = 135/\text{mm}^3.
To determine the severity of the neutropenia based on the complete blood count with differential.
2
Identify the clinical syndrome and its etiology.
The patient has febrile neutropenia (ANC<500/mm3\text{ANC} < 500/\text{mm}^3 with fever >38.3∘C> 38.3^\circ\text{C}), secondary to methimazole-induced agranulocytosis.
Antithyroid drugs (methimazole, propylthiouracil) carry a known risk of idiosyncratic agranulocytosis, which typically presents with sudden-onset fever and sore throat within the first 90 days of therapy.
3
Determine the appropriate management setting and interventions.
The offending agent must be stopped immediately. The patient requires inpatient admission and empiric intravenous broad-spectrum antibiotics.
Febrile neutropenia is a life-threatening emergency with a high risk of rapid progression to overwhelming sepsis if not treated aggressively.

Key Concept

Evaluation and management of antithyroid drug-induced agranulocytosis (febrile neutropenia)
Estimated Time:1m 30s
Rate this question